Suppr超能文献

纤维连接蛋白及其整合素受体的上调——一种适应隔离应激的机制,促进肿瘤起始。

Upregulation of fibronectin and its integrin receptors - an adaptation to isolation stress that facilitates tumor initiation.

机构信息

Department of Pathology, Moores Cancer Center, University of California San Diego, La Jolla, CA 92037, USA.

Sanford Consortium for Regenerative Medicine, University of California San Diego, La Jolla, CA 92037, USA.

出版信息

J Cell Sci. 2023 Oct 15;136(20). doi: 10.1242/jcs.261483. Epub 2023 Oct 23.

Abstract

Tumor initiation at either primary or metastatic sites is an inefficient process in which tumor cells must fulfill a series of conditions. One critical condition involves the ability of individual tumor-initiating cells to overcome 'isolation stress', enabling them to survive within harsh isolating microenvironments that can feature nutrient stress, hypoxia, oxidative stress and the absence of a proper extracellular matrix (ECM). In response to isolation stress, tumor cells can exploit various adaptive strategies to develop stress tolerance and gain stemness features. In this Opinion, we discuss how strategies such as the induction of certain cell surface receptors and deposition of ECM proteins enable tumor cells to endure isolation stress, thereby gaining tumor-initiating potential. As examples, we highlight recent findings from our group demonstrating how exposure of tumor cells to isolation stress upregulates the G-protein-coupled receptor lysophosphatidic acid receptor 4 (LPAR4), its downstream target fibronectin and two fibronectin-binding integrins, α5β1 and αvβ3. These responses create a fibronectin-rich niche for tumor cells, ultimately driving stress tolerance, cancer stemness and tumor initiation. We suggest that approaches to prevent cancer cells from adapting to stress by suppressing LPAR4 induction, blocking its downstream signaling or disrupting fibronectin-integrin interactions hold promise as potential strategies for cancer treatment.

摘要

肿瘤起始于原发性或转移性部位是一个效率低下的过程,其中肿瘤细胞必须满足一系列条件。一个关键条件涉及到单个肿瘤起始细胞克服“隔离应激”的能力,使它们能够在恶劣的隔离微环境中存活,这些微环境的特点是营养应激、缺氧、氧化应激和缺乏适当的细胞外基质(ECM)。为了应对隔离应激,肿瘤细胞可以利用各种适应性策略来发展应激耐受和获得干性特征。在本观点中,我们讨论了诱导某些细胞表面受体和 ECM 蛋白沉积等策略如何使肿瘤细胞能够耐受隔离应激,从而获得肿瘤起始潜能。作为例子,我们强调了我们小组最近的发现,即肿瘤细胞暴露于隔离应激会上调 G 蛋白偶联受体溶血磷脂酸受体 4(LPAR4)、其下游靶标纤维连接蛋白以及两个纤维连接蛋白结合整联蛋白 α5β1 和 αvβ3。这些反应为肿瘤细胞创造了富含纤维连接蛋白的生态位,最终导致应激耐受、癌症干性和肿瘤起始。我们认为,通过抑制 LPAR4 的诱导、阻断其下游信号或破坏纤维连接蛋白-整联蛋白相互作用来防止肿瘤细胞适应应激的方法可能成为癌症治疗的潜在策略。

相似文献

3
Fibronectin-mediated upregulation of α5β1 integrin and cell adhesion during differentiation of mouse embryonic stem cells.
Cell Adh Migr. 2011 Jan-Feb;5(1):73-82. doi: 10.4161/cam.5.1.13704. Epub 2011 Jan 1.
8
Alpha5beta1 integrin mediates strong tissue cohesion.
J Cell Sci. 2003 Jan 15;116(Pt 2):377-86. doi: 10.1242/jcs.00231.
9
Upregulation of fibronectin and the α5β1 and αvβ3 integrins on blood vessels within the cerebral ischemic penumbra.
Exp Neurol. 2012 Jan;233(1):283-91. doi: 10.1016/j.expneurol.2011.10.017. Epub 2011 Oct 28.
10
De novo expression of the integrin alpha5beta1 regulates alphavbeta3-mediated adhesion and migration on fibrinogen.
J Biol Chem. 2003 Jun 13;278(24):21878-85. doi: 10.1074/jbc.M212538200. Epub 2003 Apr 3.

引用本文的文献

1
pH-sensitive fibronectin nanogels combined with UTMD for anti-atherosclerosis treatment through anti-inflammatory and antioxidant effects.
Mater Today Bio. 2025 Jul 8;33:102044. doi: 10.1016/j.mtbio.2025.102044. eCollection 2025 Aug.
4
Targeting Pancreatic Cancer Cell Stemness by Blocking Fibronectin-Binding Integrins on Cancer-Associated Fibroblasts.
Cancer Res Commun. 2025 Jan 1;5(1):195-208. doi: 10.1158/2767-9764.CRC-24-0491.
5
Integrins in cancer stem cells.
Front Cell Dev Biol. 2024 Aug 21;12:1434378. doi: 10.3389/fcell.2024.1434378. eCollection 2024.
6
The Emerging Role of LPA as an Oncometabolite.
Cells. 2024 Apr 4;13(7):629. doi: 10.3390/cells13070629.

本文引用的文献

1
Tumor-initiating cells establish a niche to overcome isolation stress.
Trends Cell Biol. 2024 May;34(5):380-387. doi: 10.1016/j.tcb.2023.08.001. Epub 2023 Aug 26.
2
Drug-induced oxidative stress in cancer treatments: Angel or devil?
Redox Biol. 2023 Jul;63:102754. doi: 10.1016/j.redox.2023.102754. Epub 2023 May 18.
3
The evolving tumor microenvironment: From cancer initiation to metastatic outgrowth.
Cancer Cell. 2023 Mar 13;41(3):374-403. doi: 10.1016/j.ccell.2023.02.016.
7
Integrin-mediated cancer progression as a specific target in clinical therapy.
Biomed Pharmacother. 2022 Nov;155:113745. doi: 10.1016/j.biopha.2022.113745. Epub 2022 Sep 28.
8
New functions of DDR1 collagen receptor in tumor dormancy, immune exclusion and therapeutic resistance.
Front Oncol. 2022 Jul 22;12:956926. doi: 10.3389/fonc.2022.956926. eCollection 2022.
9
Ligand-independent integrin β1 signaling supports lung adenocarcinoma development.
JCI Insight. 2022 Aug 8;7(15):e154098. doi: 10.1172/jci.insight.154098.
10
QR code model: a new possibility for GPCR phosphorylation recognition.
Cell Commun Signal. 2022 Mar 2;20(1):23. doi: 10.1186/s12964-022-00832-4.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验